| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0277-5379(91)90269-J |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:027753799190269J?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:027753799190269J?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 1832883 |
| P2093 | author name string | P. J. Moe | |
| F. Wesenberg | |||
| T. Stokland | |||
| J. D. Borsi | |||
| P2860 | cites work | Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples | Q24569561 |
| Nonparametric Estimation from Incomplete Observations | Q25938997 | ||
| Modulation of the antitumor effect of methotrexate by low-dose leucovorin in squamous cell head and neck cancer: a randomized placebo-controlled clinical trial | Q38139672 | ||
| Systemic clearance of methotrexate in the prognosis of acute lymphoblastic leukemia in children | Q44098607 | ||
| A comparative study on the pharmacokinetics of methotrexate in a dose range of 0.5 g to 33.6 g/m2 in children with acute lymphoblastic leukemia. | Q52593712 | ||
| Analysis of Survival Data under the Proportional Hazards Model | Q56873130 | ||
| Methotrexate infusions in poor prognosis acute lymphoblastic leukemia: II. High-dose methotrexate (HDM) in acute lymphoblastic leukemia in childhood: a pilot study from April 1981 | Q68735088 | ||
| Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia | Q72571805 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oncology | Q162555 |
| P304 | page(s) | 1006-1009 | |
| P577 | publication date | 1991-01-01 | |
| P1433 | published in | European Journal of Cancer | Q332260 |
| P1476 | title | How much is too much? Folinic acid rescue dose in children with acute lymphoblastic leukaemia | |
| P478 | volume | 27 |
| Q40558249 | Central nervous system directed therapy in acute lymphoblastic leukaemia |
| Q90135380 | Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemia |
| Q39164378 | Dorsal column myelopathy after intrathecal chemotherapy for leukemia |
| Q73318762 | Effective preventive central nervous system therapy with extended triple intrathecal therapy and the modified ALL-BFM 86 chemotherapy program in an enlarged non-high risk group of children and adolescents with non-B-cell acute lymphoblastic leukemia |
| Q80313380 | High leucovorin doses during high-dose methotrexate treatment may reduce the cure rate in childhood acute lymphoblastic leukemia |
| Q91906545 | Identifying risk factors for high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia |
| Q42403051 | Re: High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphatic leukemia |
| Q36287682 | Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia |